| 12 |
Rarok AA, Stegeman CA, Limburg PC, et al. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis [J]. J Am Soc Nephrol, 2002, 13(9):2232-2238.
|
| 13 |
Schreiber A, Otto B, Ju X, et al. Membrane proteinase 3 expression in patients with Wegener' s granulomatosis and in human hematopoietic stem cell-derived neutrophils [J]. J Am Soc Nephrol,2005, 16(7): 2216-2224.
|
| 14 |
Brachemi S, Mambole A, Fakhouri F, et al. Increased membrane expression of proteinase 3 during neutrophil adhesion in the presence of anti proteinase 3 antibodies [J]. J Am Soc Nephrol, 2007, 18(8): 2330-2339.
|
| 15 |
Bauer S, Abdgawad M, Gunnarsson L, et al. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils [J]. J Leukoc Biol, 2007, 81(2): 458-464.
|
| 16 |
von Vietinghoff S, Tunnemann G, Eulenberg C, et al. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils [J]. Blood, 2007, 109(10): 4487-4493.
|
| 17 |
Hu N, Westra J, Huitema MG, et al. Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils [J]. Arthritis Rheum, 2009, 60 (5):1548-1557.
|
| 18 |
Hess C, Sadallah S, Schifferli JA. Induction of neutrophil responsiveness to myeloperoxidase antibodies by their exposure to supernatant of degranulated autologous neutrophils [J]. Blood,2000, 96(8): 2822-2827.
|
| 19 |
Griffin SV, Chapman PT, Lianos EA, et al. The inhibition of myeloperoxidase by ceruloplasmin can be reversed by antimyeloperoxidase antibodies [J]. Kidney Int, 1999, 55 (3):917-925.
|
| 20 |
Zhang AH, Chen M, Gao Y, et al. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis [J]. Clin Immunol, 2007, 122(2): 187-193.
|
| 21 |
van der Geld YM, Stegeman CA, Kallenberg CG. B cell epitope specificity in ANCA-associated vasculitis: does it matter [J] ? Clin Exp Immunol, 2004, 137(3): 451-459.
|
| 22 |
Brooks CJ, King WJ, Radford DJ, et al. IL-1 beta production by human polymorphonuclear leucocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis [J].Clin Exp Immunol, 1996, 106(2): 273-279.
|
| 23 |
Cockwell P, Brooks CJ, Adu D, et al. Interleukin-8: A pathogenetic role in antineutrophil cytoplasmic autoantibodyassociated glomerulonephritis [J]. Kidney Int, 1999, 55(3):852-863.
|
| 24 |
Calderwood JW, Williams JM, Morgan MD, et al. ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium [J]. J Leukoc Biol, 2005, 77(1): 33-43.
|
| 25 |
De Bandt M, Meyer O, Hakim J, et al. Antibodies to proteinase-3 mediate expression of intercellular adhesion molecule-1 (ICAM-1,CD 54) [J]. Br J Rheumatol, 1997, 36(8): 839-846.
|
| 26 |
Yang JJ PG, Pendergraft WF, Segelmark M, et al. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants [J]. Am J Pathol, 2001, 158(2): 581-592.
|
| 27 |
Mayet W, Schwarting A, Barreiros AP, et al. Anti-PR-3 antibodies induce endothelial IL-8 release [J]. Eur J Clin Invest, 1999, 29(11): 973-979.
|
| 28 |
Berger SP, Seelen MA, Hiemstra PS, et al. Proteinase 3, the major autoantigen of Wegener's granulomatosis, enhances IL-8 production by endothelial cells in vitro [J]. J Am Soc Nephrol, 1996, 7(5):694-701.
|
| 29 |
Mayet WJ, Csernok E, Szymkowiak C, et al. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis [J]. Blood, 1993, 82(4):1221-1229.
|
| 30 |
Xiao H, Heeringa P, Hu P, et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice [J]. J Clin Invest, 2002, 110 (7):955-963.
|
| 31 |
Huugen D, Xiao H, van Esch A, et al. Aggravation of antimyeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha [J]. Am J Pathol, 2005, 167(1): 47-58.
|
| 32 |
Little MA, Smyth CL, Yadav R, et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocytemicrovascular interactions in vivo [J]. Blood, 2005, 106(6):2050-2058.
|
| 33 |
Nolan SL, Kalia N, Nash GB, et al. Mechanisms of ANCAmediated leukocyte-endothelial cell interactions in vivo [J]. J Am Soc Nephrol, 2008, 19(5): 973-984.
|
| 34 |
Schreiber A, Xiao H, Falk RJ, et al. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies [J]. J Am Soc Nephrol, 2006, 17(12): 3355-3364.
|
| 35 |
Pfister H, Ollert M, Frohlich LF, et al. Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo [J]. Blood, 2004, 104(5):1411-1418.
|
| 36 |
Weidner S, Carl M, Riess R, et al. Histologic analysis of renal leukocyte infiltration in antineutrophil cytoplasmic antibodyassociated vasculitis: importance of monocyte and neutrophil infiltration in tissue damage [J]. Arthritis Rheum, 2004, 50(11):3651-3657.
|
| 37 |
Chen M, Wang F, Zhao MH. Circulating neutrophil gelatinaseassociated lipocalin: a useful biomarker for assessing disease activity of ANCA-associated vasculitis [J]. Rheumatology (Oxford), 2009,48(4): 355-358.
|
| 38 |
Xiao H, Heeringa P, Liu Z, et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies[J]. Am J Pathol, 2005, 167(1): 39-45.
|
| 39 |
Kessenbrock K, Krumbholz M, Schonermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis [J]. Nat Med,2009, 15(6): 623-625.
|
| 1 |
Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides[J]. Arthritis Rheum, 2013, 65(1): 1-11.
|
| 2 |
Schlieben DJ, Korbet SM, Kimura RE, et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs [J].Am J Kidney Dis, 2005,45(4):758-761.
|
| 3 |
Jayne DR, Gaskin G, Rasmussen N, et al. Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis [J]. J Am Soc Nephrol, 2007, 18(7): 2180-2188.
|
| 4 |
Mulder AH, Heeringa P, Brouwer E, et al. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA): a Fc gamma RII-dependent process [J]. Clin Exp Immunol, 1994,98(2): 270-278.
|
| 5 |
Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro [J]. Proc Natl Acad Sci USA, 1990, 87(11):4115-4119.
|
| 6 |
Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells [J]. Kidney Int, 1992, 41(2): 375-383.
|
| 7 |
Komocsi A, Lamprecht P, Csernok E, et al. Peripheral blood and granuloma CD4(+) CD28 (-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener' s granulomatosis [J]. Am J Pathol, 2002, 160(5): 1717-1724.
|
| 8 |
Kocher M, Edberg JC, Fleit HB, et al. Antineutrophil cytoplasmic antibodies preferentially engage Fc gammaRIIIb on human neutrophils [J]. J Immunol, 1998, 161(12): 6909-6914.
|
| 9 |
Kettritz R, Jennette JC, Falk RJ. Crosslinking of ANCA-antigens stimulates superoxide release by human neutrophils [J]. J Am Soc Nephrol, 1997, 8(3): 386-394.
|
| 10 |
Schreiber A, Busjahn A, Luft FC, et al. Membrane expression of proteinase 3 is genetically determined [J]. J Am Soc Nephrol,2003, 14(1): 68-75.
|
| 11 |
Witko-Sarsat V, Lesavre P, Lopez S, et al. A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis [J]. J Am Soc Nephrol, 1999,10(6): 1224-1233.
|
| 40 |
Chen M, Kallenberg CG. Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides [J]. Nephrol Dial Transplant, 2009, 24(12): 3618-3620.
|
| 41 |
Xiao H, Schreiber A, Heeringa P, et al. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies [J]. Am J Pathol, 2007, 170(1):52-64.
|
| 42 |
Gou S-J, Yuan J, Chen M, et al. Circulating complement activation in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis [J]. Kidney Int, 2013, 83(1): 129-137.
|
| 43 |
Gou SJ, Yuan J, Wang C, et al. Alternative complement pathway activation products in urine and kidneys of patients with ANCAassociated GN [J]. Clin J Am Soc Nephrol, 2013, 8(11):1884-1891.
|
| 44 |
Xing G-q, Chen M, Liu G, et al. Complement activation is involved in renal damage in human antineutrophil cytoplasmic autoantibody associated pauci-immune vasculitis [J]. J Clin Immun, 2009, 29(3): 282-291.
|
| 45 |
Hao J, Wang C, Yuan J, et al. A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation [J]. PLoS One, 2013, 8(6): e66305.
|
| 46 |
Hao J, Chen M, Zhao MH. Involvement of protein kinase C in C5aprimed neutrophils for ANCA-mediated activation [ J]. Mol Immunol, 2013, 54(1): 68-73.
|
| 47 |
Camous L, Roumenina L, Bigot S, et al. Complement alternative pathway acts as a positive feedback amplification of neutrophil activation [J]. Blood, 2011, 117(4): 1340-1349.
|
| 48 |
Schreiber A, Xiao H, Jennette JC, et al. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis [J]. J Am Soc Nephrol, 2009, 20(2): 289-298.
|
| 49 |
Xiao H, Dairaghi DJ, Powers JP, et al. C5a receptor (CD88)blockade protects against MPO-ANCA GN [J]. J Am Soc Nephrol,2014, 25(2): 225-231.
|
| 50 |
Yuan J, Gou S-J, Huang J, et al. C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis[J]. Arthritis Res Ther, 2012, 14(3): R140.
|
| 51 |
Hao J, Meng L-Q, Xu P-C, et al. p38MAPK, ERK and PI3K signaling pathways are involved in C5a-primed neutrophils for ANCA-mediated activation [J]. PLoS One, 2012, 7(5): e38317.
|
| 52 |
Guilpain P, Mouthon L. Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases [ J]. Clin Rev Allergy Immunol, 2008, 35(1-2): 59-65.
|
| 53 |
Del Papa N, Guidali L, Sironi M, et al. Anti-endothelial cell IgG antibodies from patients with Wegener' s granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion [J]. Arthritis Rheum, 1996, 39(5): 758-766.
|
| 54 |
Savage CO, Pottinger BE, Gaskin G, et al. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies [J]. Clin Exp Immunol, 1991, 85(1):14-19.
|
| 55 |
Sebastian JK, Mahr AD, Ahmed SS, et al. Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations [ J]. J Rheumatol, 2007, 34(5): 1027-1031.
|
| 56 |
Yu F, Zhao MH, Zhang YK, et al. Anti-endothelial cell antibodies(AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity [J]. Clin Exp Immunol, 2005, 139(3): 569-574.
|
| 57 |
Gobel U, Eichhorn J, Kettritz R, et al. Disease activity and autoantibodies to endothelial cells in patients with Wegener' s granulomatosis [J]. Am J Kidney Dis, 1996, 28(2): 186-194.
|
| 58 |
Holmen C, Christensson M, Pettersson E, et al. Wegener' s granulomatosis is associated with organ-specific antiendothelial cell antibodies [J]. Kidney Int, 2004, 66(3): 1049-1060.
|
| 59 |
Lamprecht P. Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides [J]. Clin Exp Immunol,2005, 141(2): 201-210.
|
| 60 |
Giscombe R, Nityanand S, Lewin N, et al. Expanded T cell populations in patients with Wegener' sgranulomatosis:characteristics and correlates with disease activity [J]. J Clin Immunol, 1998, 18(6): 404-413.
|
| 61 |
Clayton AR SC. Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis[J]. Clin Exp Immunol, 2003, 132(1): 174-179.
|
| 62 |
Spiegelberg HL. Fc receptors for IgE and interleukin-4 induced IgE and IgG4 secretion [J]. J Invest Dermatol, 1990, 94(6 Suppl):49S-52S.
|
| 63 |
Vercelli D. One cytokine, two isotypes: a trojan horse, pandora's box, and an evolving paradigm [J]. Am J Respir Crit Care Med,2000, 162(3 Pt 2): S86-S90.
|
| 64 |
King WJ, Brooks CJ, Holder R, et al. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission [J]. Clin Exp Immunol, 1998, 112(3): 539-546.
|
| 65 |
Sanders JS, Stegeman CA, Kallenberg CG. The Th1 and Th2 paradigm in ANCA-associated vasculitis [J]. Kidney Blood Press Res, 2003, 26(4): 215-220.
|
| 66 |
Abdulahad WH, Stegeman CA, Limburg PC, et al. Skewed distribution of Th17 lymphocytes in patients with Wegener' s granulomatosis in remission [J]. Arthritis Rheum, 2008, 58(7):2196-2205.
|
| 67 |
Jin D, Zhang L, Zheng J, et al. The inflammatory Th 17 subset in immunity against self and non-self antigens [J]. Autoimmunity,2008, 41(2): 154-162.
|
| 68 |
Steinmetz OM, Velden J, Kneissler U, et al. Analysis and classification of B-cell infiltrates in lupus and ANCA-associated nephritis [J]. Kidney Int, 2008, 74(4): 448-457.
|